These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4614247)

  • 41. Esophageal acid exposure on proton pump inhibitors in unselected asymptomatic gastroesophageal reflux disease patients.
    Grigolon A; Cantù P; Savojardo D; Conte D; Penagini R
    J Clin Gastroenterol; 2008 Oct; 42(9):969-73. PubMed ID: 18719508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group.
    Castell DO; Sigmund C; Patterson D; Lambert R; Hasner D; Clyde C; Zeldis JB
    Am J Gastroenterol; 1998 Apr; 93(4):547-52. PubMed ID: 9576446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of metoclopramide on gastro-oesophageal reflux.
    Bennett JR; Stanciu C
    Postgrad Med J; 1973 Jul; 49 Suppl 4():suppl 4:65-9. PubMed ID: 4804469
    [No Abstract]   [Full Text] [Related]  

  • 44. [Pathophysiology, clinical aspects and therapy of gastro-esophageal reflux disease].
    Fahrländer H
    Schweiz Med Wochenschr; 1981 Apr; 111(16):550-5. PubMed ID: 7233133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Postoperative vomiting treated with domperidone. A double-blind comparison with metoclopramide and a placebo.
    Boghaert A; Carron D; Gallant J; Stockman A
    Acta Anaesthesiol Belg; 1980; 31(2):129-37. PubMed ID: 7008487
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nizatidine versus placebo in gastro-oesophageal reflux disease: a 12-week, multicentre, randomised, double-blind study.
    Cloud ML; Offen WW; Robinson M
    Br J Clin Pract Suppl; 1994 Nov; 76():3-10. PubMed ID: 7794701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Randomized double-blind trial with a liquid suspension of alginate for the treatment of pyrosis].
    Filoche B; Carteret E; Couzigou B; Guerder A; Lombard M; Pouts-Lajus P; Sans J; Poynard T; Juif-Bielsky MC; Richard-Berthe C
    Gastroenterol Clin Biol; 1991; 15(12):984-5. PubMed ID: 1783259
    [No Abstract]   [Full Text] [Related]  

  • 48. Cisapride for gastroesophageal reflux disease: a placebo-controlled, double-blind study.
    Richter JE; Long JF
    Am J Gastroenterol; 1995 Mar; 90(3):423-30. PubMed ID: 7872282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Stimulation of esophageal motility with bromoprid, domperidon and metoclopramide. Therapy of esophageal reflux disease].
    Lux G; Engel H; Rösch W
    Fortschr Med; 1980 May; 98(18):708-11. PubMed ID: 7390390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High- versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial.
    Kahrilas PJ; Fennerty MB; Joelsson B
    Am J Gastroenterol; 1999 Jan; 94(1):92-7. PubMed ID: 9934737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does oral metoclopramide increase cardiac sphincter pressure?
    Dilawari JB; Misiewicz JJ
    Gut; 1972 Oct; 13(10):856. PubMed ID: 5087122
    [No Abstract]   [Full Text] [Related]  

  • 52. [Heartburn without esophagitis. Symptoms more important than the finding?].
    Füessl HS
    MMW Fortschr Med; 2003 Sep; 145(39):4-6. PubMed ID: 14649061
    [No Abstract]   [Full Text] [Related]  

  • 53. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prokinetic therapy for gastroesophageal reflux disease.
    Robinson M
    Am Fam Physician; 1995 Sep; 52(3):957-62, 965-6. PubMed ID: 7653432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ranitidine in the treatment of symptomatic gastroesophageal reflux disease.
    Sherbaniuk R; Wensel R; Bailey R; Trautman A; Grace M; Kirdeikis P; Jewell L; Pare P; Levesque D; Farley A
    J Clin Gastroenterol; 1984 Feb; 6(1):9-15. PubMed ID: 6321588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cholinergic therapy of chronic heartburn. A controlled trial.
    Farrell RL; Roling GT; Castell DO
    Ann Intern Med; 1974 May; 80(5):573-6. PubMed ID: 4596046
    [No Abstract]   [Full Text] [Related]  

  • 57. [Manometric evaluation of drug therapy in gastroesophageal reflux].
    Caro Pérez F; Sancho Fornos S; García Fresquet JV; Valero Rustarazo J
    Rev Esp Enferm Apar Dig; 1983 Mar; 63(3):256-65. PubMed ID: 6867428
    [No Abstract]   [Full Text] [Related]  

  • 58. Successful administration of metoclopramide for the treatment of nausea in patients with advanced liver disease. A double-blind controlled trial.
    Uribe M; Ballesteros A; Strauss R; Rosales J; Garza J; Villalobos A; Briones A; Garcia Ramos G
    Gastroenterology; 1985 Mar; 88(3):757-62. PubMed ID: 3881309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cimetidine and metoclopramide in oesophageal reflux disease.
    Temple JG; Bradby GV; O'Connor FO; Panesar KS; Mulligan TO; Robinson TJ; Ward DW
    Br Med J (Clin Res Ed); 1983 Jun; 286(6381):1863-4. PubMed ID: 6407606
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effect of metoclopramide on pentagastrin-stimulated gastroesophageal reflux].
    Pfliuke F; Linar EIu
    Sov Med; 1985; (2):97-9. PubMed ID: 3992334
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.